ENDEFR
Home › United States › TELIX PHARMACEUTICALS (INVESTMENTS) INC.

TELIX PHARMACEUTICALS (INVESTMENTS) INC.

Corporation · DOVER, United States · LEI 254900CWDJI1DLWYA524
LEI active

Summary

TELIX PHARMACEUTICALS (INVESTMENTS) INC. is registered in the United States. Its legal form is Corporation. According to GLEIF, its ultimate parent is TELIX PHARMACEUTICALS LIMITED (Australia). That group has 1 subsidiary with LEIs in 2 countries, 1 of them in the United States. The LEI was first issued on 24 Mar 2026 and the record was last updated on 24 Mar 2026; the next renewal is due by 24 Mar 2027.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formCorporation
Register · Register website
Registration number10540812
Registration authorityDivision of Corporations, Department of State
JurisdictionUnited States (US-DE)
Registered addressC/O UNITED CORPORATE SERVICES, INC., 800 NORTH STATE STREET, 19901 DOVER, United States
Headquarters address11700 Exit 5 Pkwy, 46037 Fishers, United States
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)10 Mar 2026
LEI254900CWDJI1DLWYA524
LEI statusactive
LEI first issued24 Mar 2026
LEI record last updated24 Mar 2026
Next LEI renewal24 Mar 2027
Corroboration of the LEI recordfully corroborated

Group membership

TELIX PHARMACEUTICALS LIMITED Australia ultimate parent
TELIX PHARMACEUTICALS (INVESTMENTS) INC. this entity

Relationship to the parent

Ultimate parent
ParentTELIX PHARMACEUTICALS LIMITED
Accounting period16 Mar 2026 to 31 Dec 2026
Evidenceother official documents
Corroborationsupplied by the entity only
Accounting standardIFRS
Consolidation percentage reported to GLEIF100.00%
Relationship start16 Mar 2026
Recorded at GLEIF since24 Mar 2026
Last updated24 Mar 2026
Record statuscurrent

Parent not reported to GLEIF

  • Direct parent: the parent has no LEI and has not consented to obtain one.